Medicines lifecycle is critical to fostering patient access to innovative therapeutic solutions, and delivering better health outcomes for patients.

Latest resource

Main deliverables

Main deliverable

Sort by
Sort by

PARADIGM – 1st Open Patient Engagement Forum 2018

Patients Active in Research and Dialogues for an Improved Generation of Medicines (PARADIGM) had its first Open Patient Engagement Forum on the 10th of April in Brussels co-organised by PARADIGM, PFMD and EUPATI. The forum had four workshops focusing on prioritisation of the PARADIGM survey topics, building the PARADIGM story, assessing the value of patient engagement and utilising the survey to identify key stakeholders and most suited methodologies for the project. Follow the link for a short report on the events of the day:

20 June, 2018

Communications and External Engagement Plan

The Communications and Engagement plan lays down the map for PARADIGM communications activities throughout the project. It sets the guidelines for upcoming communication events, on stakeholders to reach, on the key messaging and the tools to use to reach them.

31 May, 2018

PARADIGM’s digital assets

The success of PARADIGM is closely linked to the dissemination and adoption of the outcomes of the project. PARADIGM aims at ensuring an extensive outreach to a broad set of stakeholders within the medicines development community at large. In order to do that a set of digital assets were developed.

23 January, 2017

Report on the first open Patient Engagement Forum

The PARADIGM consortium led by European Patients’ Forum and EFPIA held its first forum on 10th of April 2018, which was co-organized by EUPATI (European Patients’ Academy on Therapeutic Innovation) and PFMD (Patient Focused Medicines Development).

31 May, 2018